These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 26848041)

  • 1. Nanoparticle formulations of cisplatin for cancer therapy.
    Duan X; He C; Kron SJ; Lin W
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):776-91. PubMed ID: 26848041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-based nanoparticles as platform technologies for modern vaccines.
    Lee KL; Twyman RM; Fiering S; Steinmetz NF
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Jul; 8(4):554-78. PubMed ID: 26782096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional platinum-based nanoparticles for biomedical applications.
    Cheng Q; Liu Y
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Mar; 9(2):. PubMed ID: 27094725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modifying the tumor microenvironment using nanoparticle therapeutics.
    Roy A; Li SD
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Nov; 8(6):891-908. PubMed ID: 27038329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymeric nanoparticles in development for treatment of pulmonary infectious diseases.
    Lim YH; Tiemann KM; Hunstad DA; Elsabahy M; Wooley KL
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Nov; 8(6):842-871. PubMed ID: 27016134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systems-level thinking for nanoparticle-mediated therapeutic delivery to neurological diseases.
    Curtis C; Zhang M; Liao R; Wood T; Nance E
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Mar; 9(2):. PubMed ID: 27562224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted nanoparticles for head and neck cancers: overview and perspectives.
    Zhao Y; Chen H; Chen X; Hollett G; Gu Z; Wu J; Liu X
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Nov; 9(6):. PubMed ID: 28387452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomedicine approaches to improve cancer immunotherapy.
    Qiu H; Min Y; Rodgers Z; Zhang L; Wang AZ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Sep; 9(5):. PubMed ID: 28296286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional nanoparticle composites: progress in the use of soft and hard nanoparticles for drug delivery and imaging.
    Sangtani A; Nag OK; Field LD; Breger JC; Delehanty JB
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Nov; 9(6):. PubMed ID: 28299903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the development of aptamer drug conjugates for targeted drug delivery.
    Chen K; Liu B; Yu B; Zhong W; Lu Y; Zhang J; Liao J; Liu J; Pu Y; Qiu L; Zhang L; Liu H; Tan W
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 May; 9(3):. PubMed ID: 27800663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of nanoparticles to deliver immunomodulatory oligonucleotides.
    Klinman DM; Sato T; Shimosato T
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Jul; 8(4):631-7. PubMed ID: 26663867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted nanomedicine in cisplatin-based cancer therapeutics.
    Han Y; Wen P; Li J; Kataoka K
    J Control Release; 2022 May; 345():709-720. PubMed ID: 35367476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in preclinical to clinical translation for anticancer carrier-mediated agents.
    Lucas AT; Madden AJ; Zamboni WC
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):642-53. PubMed ID: 26846457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design considerations for nanotherapeutics in oncology.
    Stylianopoulos T; Jain RK
    Nanomedicine; 2015 Nov; 11(8):1893-907. PubMed ID: 26282377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent progress in nanotechnology-based novel drug delivery systems in designing of cisplatin for cancer therapy: an overview.
    Farooq MA; Aquib M; Farooq A; Haleem Khan D; Joelle Maviah MB; Sied Filli M; Kesse S; Boakye-Yiadom KO; Mavlyanova R; Parveen A; Wang B
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1674-1692. PubMed ID: 31066300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide nanostructures in biomedical technology.
    Feyzizarnagh H; Yoon DY; Goltz M; Kim DS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):730-43. PubMed ID: 26846352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle drug-delivery systems for peritoneal cancers: a case study of the design, characterization and development of the expansile nanoparticle.
    Colby AH; Oberlies NH; Pearce CJ; Herrera VL; Colson YL; Grinstaff MW
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 May; 9(3):. PubMed ID: 28185434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-platelet agents augment cisplatin nanoparticle cytotoxicity by enhancing tumor vasculature permeability and drug delivery.
    Pandey A; Sarangi S; Chien K; Sengupta P; Papa AL; Basu S; Sengupta S
    Nanotechnology; 2014 Nov; 25(44):445101. PubMed ID: 25302488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Label-free detection and manipulation of single biological nanoparticles.
    DeSantis MC; Cheng W
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):717-29. PubMed ID: 26846164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.